Health Catalyst Partners with Datavant to Expand Access to Clinical Trials as a Care Option for Patients
Health Catalyst, Inc. (HCAT) has announced a strategic partnership with Datavant to enhance research and clinical care through connected health data.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Health Catalyst, Inc. (HCAT) has announced a strategic partnership with Datavant to enhance research and clinical care through connected health data. This collaboration aims to reduce waste in patient recruitment for clinical trials by using tokenized, de-identified data within the Health Catalyst Research Network™. The partnership will facilitate data connectivity throughout the study life cycle, improving pre-trial feasibility, patient eligibility, and long-term safety analysis. Leaders from both companies emphasize the potential to broaden patient access and improve health outcomes through better data sharing.
Positive
- Strategic partnership with Datavant to enhance clinical trial efficiency.
- Improved access to health data may increase eligible patient recruitment.
- Potential for new discoveries and treatments through better data connectivity.
Negative
- None.
Details
News Market Reaction – HCAT
The recorded move for HCAT in the trading session of this news was +2.32%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY and SAN FRANCISCO, Nov. 16, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data, analytics and technology services to healthcare and life sciences organizations, and Datavant, the leader in helping organizations securely connect health data, today announced a strategic partnership to improve research and care delivery with connected health data.
The partnership between Datavant and Health Catalyst will enable life sciences and healthcare organizations to exchange tokenized, de-identified data within the recently announced Health Catalyst Research Network™ and Health Catalyst Touchstone Match™. "Tremendous waste occurs from failing to recruit patients truly eligible for trials. Improved collaboration through connected healthcare data during the clinical trial process can help solve this problem and increase the potential for new discoveries and treatments for patients," said Sadiqa Mahmood, General Manager & Senior Vice President, Life Sciences Business, at Health Catalyst.
The collaboration will enable data connectivity across the entire study life cycle. Increased access to health data will speed pre-trial feasibility, recruitment and patient eligibility confirmation. It will also augment insight during the trial by adding depth to data collected on each patient. After trials conclude, connecting data like claims and electronic health records can support long-term effectiveness and safety analysis.
"Connected health data can broaden the pool of eligible patients who have access to trials and help address health disparities," said Travis May, President and Founder of Datavant. "We're excited to partner with Health Catalyst to expand the reach, speed and insight from clinical trials by removing the bottlenecks to accessing broader patient data sets."
About Health Catalyst
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data-informed.
About Datavant
Datavant's mission is to connect the world's health data to improve patient outcomes. Datavant works to reduce the friction of data sharing across the healthcare industry by building neutral, trusted and ubiquitous technology that protects the privacy of patients while supporting the exchange of identified and de-identified health data across tens of thousands of healthcare institutions.
Media Contacts:
Amanda Hundt
Vice President, Corporate Communications
amanda.hundt@healthcatalyst.com
Elenee Argentinis
Head of Marketing, Datavant
elenee@datavant.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/health-catalyst-partners-with-datavant-to-expand-access-to-clinical-trials-as-a-care-option-for-patients-301424643.html
SOURCE Datavant
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.